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Abstract. Non-adherence to the treatment of chronic diseases such as hypertension and 
Diabetes Mellitus (DM) is a major obstacle in achieving patient therapy targets and quality of 
life of patients. A comprehensive approach involving pharmacists counselling has shown 
influences on changes in health behaviour and patient compliance. Behaviour changes in 
patients are one of the parameters to assess the effectiveness of counselling and education by 
pharmacists. Therefore, it is necessary to develop questionnaires of behaviour change 
measurement in DM-hypertension patients. This study aims to develop a measurement 
instrument in the form of questionnaires in assessing the behaviour change of DM-
hypertension patients. Preparation of question items from the questionnaire research instrument 
refers to some guidelines and previous research references. Test of questionnaire instrument 
valid was done with expert validation, followed by pilot testing on 10 healthy respondents, and 
10 DM-hypertension patients included in the inclusion criteria. Furthermore, field validation 
test was conducted on 37 patients who had undergone outpatient care at the PKU 
Muhammadiyah Yogyakarta City Hospital and The Gading Clinic in Yogyakarta. The 
inclusion criteria were male and female patients, aged 18-65, diagnosed with type 2 diabetes 
with hypertension who received oral antidiabetic drugs and antihypertensives, and who were 
not illiterate and co-operative. The data were collected by questionnaire interviews by a 
standardized pharmacist. The result of validation test using Person correlation shows the value 
of 0.33. The results of the questionnaire validation test on 37 patients showed 5 items of 
invalid questions with the value of r <0.33, e: questions 2, 3, 6, 10 and 11, while the other 10 
questions show the value of Pearson correlation > 0.33. The reliability value is shown from the 
Cronbach’s alpha value of 0.722 (> 0.6), implying that the questionnaire is reliable for DM-
hypertension patients. This Behavioural change questionnaire can be used on DM-hypertension 
patients, and an FGD approach is required for the development of factors affecting this 
questionnaire. 
 
Keywords: DM-hypertension, behaviour, compliance, validation, reliability 
1.  Introduction 
Diabetes mellitus (DM) is a chronic condition that can cause many serious complications, such as 
cardiovascular, nephropathic, retinopathic, and neuropathic diseases, which raise chronic illness and 
mortality rates [1]. Data show that every seven minutes a person succumbs to diabetes mellitus [2]. 
According to WHO data, it is estimated that the world population will undergo an increase in diabetes 
mellitus prevalence in the period of 2000-2030 from 37% to 114% [3]. The International Diabetes 
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Federation also predicts that 246 million adults have DM. DM prevalence in adults in the world has 
reached 6.4% and will rise to 7.7% in 2030. It is projected that between 2010 and 2030 there will be a 
69% increment of adult DM patients in developing countries, and 20% in developed ones [4].   
High blood pressure is a significant predictor of nephropathy, retinopathy, and cardiovascular 
disorder in type 2 diabetes [4]. Prior studies emphasised the importance of diabetes education from 
professional health services on DM therapy and management, lifestyle education including diet, 
physical exercise, blood sugar level monitoring, foot treatment, and treatment modification that can 
improve the clinical outcome and quality of life of DM patients [5, 6, 7]. Educated knowledge about 
DM management influences changes in the behaviour and self-management of DM patients [7, 8].   
Three domains that affect behaviour are cognitive, affective and psychomotor [9, 10].  Behaviour is 
one’s response or reaction to a stimulus. Behaviour is determined by three main factors: Predisposing 
factors, or factors that precede behaviour, which account for the reason and motivation for certain 
behaviour, such as knowledge, beliefs, attitude and demography; enabling factors, such as the 
availability and affordability of health resources and skills related to health, which allow particular 
behaviour to materialise; reinforcing factors, which accompany behaviour and play a role in 
establishing certain behaviour, including family, peers, teachers, and health workers [11, 12, 13].   
Previous research on the relationship between knowledge about DM, health beliefs, and DM 
management revealed that the knowledge of DM patients augments their comprehension of DM 
management (β = 0.262, t = 3.328, p = 0.001), and that health beliefs affect DM patients’ knowledge 
(β=0.07865, t=2.439, p<.016). Such investigation employed the “Health Belief Model” theoretical 
approach to explain self-care activities, such as recommended DM management, and focus on 
behaviour relating to disease prevention [7, 14].   
The American Association of Diabetes Educators has developed standards for measuring the 
outcomes of DM self-management education. One of the recommended standards of diabetes self-care 
behaviour in DM management is assessing seven self-care behaviours, comprising physical activities, 
diets, the use of medicinal therapy and management, blood sugar level monitoring, overcoming 
hypoglycaemia occurrences, declines in DM complications, and psychosocial adaptation in living life 
[7,8].   
A preceding study found that education and counselling by Brief Counselling 5A on hypertension 
patients can influence changes in their behaviour [9]. Modified Brief Counselling 5A is developed 
through five stages: Assess, the stage of current behaviour, the importance of changing it, the level of 
readiness for change, and social support; Advise, where individual behaviour clearly and specifically 
changes, including information about personal health gains and losses;  Agree, which is the stage of 
collaboration towards the targeted behaviour; Assist, where help is given to solve various problems in 
order to achieve the expected behavioural change; Arrange, in which further actions are taken to 
evaluate progress and hurdles, and to adjust planning [15]. 
The behavioural change of a patient into greater compliance can be used as parameter in assessing 
the effectiveness of education and counselling by a pharmacist [2]. Instruments measuring therapeutic 
compliance have been widely developed, but instruments gauging patients’ behaviour by assessing 
their change and readiness have yet to receive the same attention, raising the need to develop a DM-
hypertension patient behaviour measurement instrument. 
 
2.  Materials and Methods 
2.1.  Methods 
This study was reviewed and approved by the Research Ethics Committee of Universitas Ahmad 
Dahlan, numbered EC 011610143. The arrangement of question items in the research questionnaire 
instrument referred to guidelines and prior studies. The development of the DM-hypertension patient 
behaviour measurement instrument utilised a research and development design by a pharmacist and a 
researcher. The questionnaire draft was then reviewed by a psychology expert and an expert researcher 
of endocrines. The validity test for the questionnaire instrument was done by expert validation, with 
pilot testing on 10 healthy respondents and 10 DM-hypertension patients within the inclusion criteria 
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[2]. Next, a field validation test was conducted on 37 patients under outpatient care at the PKU 
Muhammadiyah Hospital and the Gading Clinic, both in the city of Yogyakarta [11, 12].  The 
inclusion criteria were male and female patients aged 18-65 diagnosed with type 2 diabetes with 
hypertension who received oral antidiabetic drugs and antihypertensives, and who were not illiterate 
and co-operative. Data were collected by means of questionnaire interviews given by standardised 
pharmacists. Statistical analysis of validity used Pearson correlation, and factor analysis. Reliability 
test used Cronbach’s alpha value.  
2.2.  Materials 
The DM-hypertension patient behaviour measurement instrument consists of 15 question items in 
cognitive, affective and psychomotor domains, given in Indonesian. The cognitive domain contains 
questions on knowledge about DM-hypertension disorders, complications, and the therapeutic 
management of oral antidiabetic and antihypertensive drugs. The affective domain comprises 
questions related to the feelings and preconceptions of patients regarding regular oral antidiabetic and 
antihypertension medications to control their blood sugar and blood pressure levels. The psychomotor 
domain enquires patients’ behaviour towards compliance in taking medications, diet including the 
consumption of carbohydrate, sugar and salt, and ceasing medication without consulting the doctor.  
The questionnaire employs yes-no questions, for which a “yes” answer is scored 1 and a “no” is 
given 0, except for items number 9, 14, and 15 where a “no” is scored 1, and a “yes” response 0. 
Patient behavioural levels measured by the questionnaire are categorised into pre-contemplation (if 
there is no affirmative answer in the cognitive, affective, and psychomotor domains), contemplation (if 
the answers are affirmative only in the cognitive domain), preparation (if the answers are affirmative 
only in the cognitive and affective domains), and action (if the answers are affirmative in all three 
domains). 
 
3. Results and Discussion 
This research aims to develop a DM-hypertension patient behaviour measurement instrument. The 
arrangement of the question items referred to previous studies and DM-hypertension management 
guidelines. The questionnaire validation test was carried out at the PKU Muhammadiyah Yogyakarta 
City Hospital and the Gading Clinic in Yogyakarta from June to August 2016. As subjects of this 
preliminary study, 45 DM type 2 patients with hypertension meeting the inclusion criteria were 
obtained, but 8 patients were excluded because they could not follow the research to the end, leaving 
37 patients for this validation test. Description of the demographical characteristics of patients in this 
study is presented in Table 1.  
The patients were predominantly women (70.3%), married (91.9%), and aged 60 or over (59.5%), 
and their last education was mostly at senior high school (48.6%). Most of them were merchants, 
pensioners and housewives (62.2%), and were covered by the government (BPJS) (78.4%). The 
majority of patients did not have diabetes mellitus history (51.4%), practiced a diet controlling the 
consumption of salt, sugar and coffee (89.2%), and did not smoking (94.6%).  
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Table 1. Demographical characteristics of patients for questionnaire validation 
Demographical characteristic n No (%) / Mean ±SD 
Sex    
Female  26 70.3% 
Male  11 29.7% 
Marital status    
Married  34 91.9% 
Not married  3 8.1% 
Age   
<60 15 40.5% 
≥60 22 59.5% 
Body weight (kg)   64.62 ±11.82 
Body height (m)   1.57 ±0.07 
Body mass index  25.97 ±4.10 
Education    
Primary school 9 24.3% 
Junior high school 6 16.2% 
Senior high school 18 48.6% 
D1/D2/D3/S1 3 8.1% 
No school education  1 2.7% 
Occupation    
Civil servant 1 2.7% 
Entrepreneur  4 10.8% 
Private employee  3 8.1% 
Unemployed  5 13.5% 
Other  23 62.2% 
Payment    
Self-funded  2 5.4% 
BPJS 29 78.4% 
Other insurance  6 16.2% 
Diabetes mellitus history    
Yes  18 48.6% 
No  19 51.4% 
Diet    
Salt and sugar 3 8.1% 
Coffee  1 2.7% 
Salt, sugar and coffee  33 89.2% 
Habit    
Smoking  2 5.4% 
Not smoking  35 94.6% 
 
3.1.  Behavioural Level Questionnaire Validation  
Results of the behavioural level questionnaire validity and reliability tests are provided in Table 2. The 
validity test by Pearson correlation resulted in a value greater (>) than critical r, namely > 0.33. 
Validation of the questionnaire on 37 patients disclosed five invalid question items with r < 0.33, 
which were questions number 2, 3, 6, 10 and 11, while the other ten questions had a Pearson 
correlation coefficient of r > 0.33. Reliability was affirmed by a Cronbach’s alpha value of 0.722 
(>0.6), indicating that this behaviour measurement questionnaire is reliable for DM-hypertension 
patients.  
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The re-validity test was done by removing the invalid item, and a number of 10 question items 
showed the value of r > 0.3, with the Cronbach’s alpha value being 0.722 (> 0.6) (Table 3). Several 
questions 2, 3, 6, 10 and 11 showed invalid, this can be seen from the answers of patients who are 
mostly uniform. This indicates that the questionnaire's differentiation is quite low, in addition to the 
question asked too easily so it can not distinguish the answers between patients. Question number 2 
and 3 are designed in the cognitive domain, the whole patient answers "yes" and the uniform answer 
makes the validation value low. Become input for the researcher related to sentence question in item 2 
and 3. While question number 6 is arranged in the affective domain, it also showed uniform answer so 
that validation value was low. In the psychomotor domain the behavioral adherence behavior is shown 
from items 10 and 11. 
  
Table 2. Results of validation and reliability test of the DM-hypertension patient behavioural level 
questionnaire 
No. Question Mean SD 
Pearson 
correlation 
(r>0.33) 
N=37 
Cronbach’s 
alpha 
(when item 
deleted) 
COGNITIVE     
1 Do you know that diabetes mellitus with 
hypertension complication is a dangerous disease?  
0.9189 0.27672 0.489 0.708 
2 Do you know that antidiabetic drugs must be used 
continuously to control blood sugar level? 
  (invalid)  
3 Do you know that antihypertension drugs must be 
used continuously to control blood pressure? 
  (invalid)  
4 Do you know that untreated high blood pressure 
will cause blood vessel damage and trigger heart 
disorder and stroke? 
0.9189 0.27672 0.651 0.697 
5 Do you know that high blood sugar level and blood 
pressure will cause functional disorder of other 
organs, such as the kidneys and incurable wounds? 
0.8919 0.31480 0.573 0.700 
AFFECTIVE     
6 Do you believe that using antidiabetic drugs can 
control blood sugar level? 
  (invalid)  
7 Do you believe that using antihypertension drugs 
can control blood pressure? 
0.9459 0.22924 0.459 0.712 
8 Do you have the willingness to use antidiabetic and 
antihypertension drugs regularly to control blood 
sugar level and blood pressure? 
0.9730 0.16440 0.456 0.717 
9 Do you presume that using antihypertension drugs 
continuously can damage the kidneys? 
0.4324 0.50225 0.373 0.719 
PSYCHOMOTOR     
10 Do you always bring antidiabetic drugs when 
travelling or working? 
  0.058 
(invalid) 
 
11 Do you always bring antihypertension drugs when 
travelling or working? 
  0.134 
(invalid) 
 
12 Have you reduced sugar consumption to control 
blood sugar level? 
0.9459 0.22924 0.329 0.719 
13 Have you reduced salt consumption to control blood 
pressure? 
0.8108 0.39706 0.345 0.716 
14 Will you stop using antidiabetic drugs if the clinical 
symptoms of diabetes mellitus do not occur? 
0.6486 0.48398 0.750 0.666 
15 Will you stop using antihypertension drugs if the 
clinical symptoms of hypertension do not occur? 
0.6757 0.47458 0.796 0.660 
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Table 3.  Result of re-validity test of the DM-hypertension patient behavioural level questionnaire 
No Item of Question 
r (Pearson 
correlation) 
Validity 
Cognitive   
1 Item 1 0.489 Valid 
2 Item 4 0.651 Valid 
3 Item 5 0.573 Valid 
Affective   
4 Item 7 0.459 Valid 
5 Item 8 0.456 Valid 
6 Item 9 0.373 Valid 
Psychomotor   
7 Item 12 0.329 Valid 
8 Item 13 0.345 Valid 
9 Item 14 0.750 Valid 
10 Item 15 0.796 Valid 
 
Table 4. Percentage distribution of the respondents’ answers to each question item of the DM-
hypertension patient behavioural level questionnaire 
No Question Yes No 
COGNITIVE N (%) N (%) 
1 DM-hypertension is a dangerous disease. 34 (91.9) 3 (8.1) 
2 DM drugs are used regularly to control blood sugar level. 37 (100) 0 (0) 
3 Antihypertension drugs are used regularly to control blood pressure. 37 (100) 0 (0) 
4 Untreated high blood pressure will trigger heart disorder and stroke. 34 (91.9) 3 (8.1) 
5 High blood sugar level and blood pressure will cause functional disorder of 
other organs, such as the kidneys and incurable wounds. 
33 (89.2) 4 (10.8) 
AFFECTIVE   
6 Belief in the regular use of DM drugs to control blood sugar level   37 (100) 0 (0) 
7 Belief in the regular use of antihypertension drugs to control blood pressure 35 (94.6) 2 (5.4) 
8 Willingness to use antidiabetic and antihypertension drugs regularly to control 
blood sugar level and blood pressure 
36 (97.3) 1 (2.7) 
9 Presumption that long-term drug use damages the kidneys  16 (43.2) 21 (56.8) 
PSYCHOMOTOR   
10 Always carrying DM drugs when travelling  34 (91.9) 3 (8.1) 
11 Always carrying antihypertension drugs when travelling   35 (94.6) 2 (5.4) 
12 Sugar diet to control blood sugar level 35 (94.6) 2 (5.4) 
13 Salt diet to control hypertension  30 (81.1) 7 (18.9) 
14 Ceasing DM medication when clinical symptoms abate  24 (64.9) 13 (35.1) 
15 Ceasing antihypertension medication when clinical symptoms abate 25 (67.6) 12 (32.4) 
 
The results of the validation test items 10 and 11 are very low, this is because the repetition of 
almost identical questions turns the answer "yes" to the respondents. Most of the answers are uniform 
(yes = 91-94%), so the power difference is quite low. The invalidity of questions number 2, 3, 6, 10 
and 11 can be observed from the virtually uniform responses given by patients. This implies that the 
differentiating power of the questionnaire was rather low, coupled with overly easy questions that 
could not distinguish responses among patients. Further research is needed to develop this instrument 
71234567890
IPCUAD2017 IOP Publishing
IOP Conf. Series: Materials Science and Engineering 259 (2017) 012014 doi:10.1088/1757-899X/259/1/012014
 
 
 
 
 
 
through focus group discussions (FGD) to explore the understanding levels of patients. The percentage 
distribution of the respondents’ answers to each question item are given in Table 4. 
Ten valid items were then tested for validity by factor analysis to see the correlation among fellow 
indicators simultaneously [18]. The Determinant of Correlation Matrix value is 0.001, this value 
approaches 0 thus the correlation matrix between the variables is interrelated. The results showed that 
the value of Kaiser Meyer Olkin (KMO) Measure of Sampling of 0.521. The KMO complied 
requirement because the value above 0.5. The calculation results with SPSS resulted in a Barlett Test 
of Spehricity of 210,643 with a significance of 0.000. Indicated that Bartlett Test of Spehricity 
fulfilled the requirements because of significance below 0.05 (<5%). While the matrix component of 
this questionnaire were 4 factor components, with each component matrix value or factor loading > 
0.5. This indicated that ten question items were valid for use in patients with DM-hypertension [18]. 
Based on the Trans-Theoretical Model (TTM) theory developed by DiClemente, patient behaviours 
are classified into pre-contemplation, contemplation, preparation, action and maintenance [9, 14]. The 
distribution of the patients’ behavioural levels is displayed by Table 5. TTM was designed to acquire 
direct impact (expected/deliberate behavioural change) on individuals or groups. This model is the 
most widely used concept of behavioural change in health behaviour studies [16, 17]. 
 
Table 5. Distribution of DM-hypertension patient behavioural level 
Behaviour category N (%) 
Pre-contemplation 6 (16.2) 
Contemplation 17 (45.9) 
Preparation 7 (18.9) 
Action 7 (18.9) 
 
At the pre-contemplation stage, the individual does not consider or intend to alter problematic 
behaviour (start healthy behaviour) soon (within six months), because the patient usually does not 
understand facts concerning risks posed by unhealthy behaviour. Such patients need encouragement to 
become more aware of their decisions and the benefits of adopting healthy behaviour. The 
contemplation stage is where the patient becomes aware and willing to change problematic behaviour, 
and is able to consider the advantages and disadvantages of changes that one will face. The 
preparation stage sees the individual ready to take action in the near future (in 30 days ahead). At this 
level, the gains (pros) which support change towards healthy behaviour are greater than the hurdles 
(cons), and patients take small steps that they believe can help make healthy behaviour part of their 
lives. The action stage is where patients have altered their behaviour in the last six months and work 
hard to keep going forward. In TTM, an individual attaining this phase has undergone half the 
changing process, and thus is most likely to undergo relapses to unhealthy behaviour. If one is not 
sufficiently prepared for change and committed to planning actions of their choice, reversions to 
problematic behaviour would be largely possible. At the maintenance stage, the patient has 
successfully achieved and maintained behavioural change for at least six months. Risks of setbacks are 
still present but not too considerable, and the individual tries to keep practicing healthy behaviour [9, 
14, 15, 17].  
This inquiry found that most of the patients were at the contemplation behavioural level (45.9%). 
This suggests that the majority of patients had the awareness and will to change their behaviour to 
action or maintenance level. However, re-monitoring is required at least in second visits as follow-up 
to this research. Nonetheless, 16.2% patients were at pre-contemplation level, indicating that they 
were not yet prepared for and had not cognitively comprehend knowledge about DM-hypertension 
disease, and had not had the disposition to take medications regularly. This calls for intervention in the 
shape of education regarding DM-hypertension management and the motivation to improve patient 
compliance.  
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Limitations in this study are still needed FGD in digging factors that affect the understanding of 
patients, and compilation of sentences in the questionnaire items questionnaire. Interventions are 
needed in the form of education related to DM-Hypertension management and motivation in 
improving patient compliance. 
 
4. Conclusions 
This research showed that the DM-hypertension patient behaviour measurement questionnaire was 
valid and reliable. Further research in the form of FGDs is required to divulge factors which affect 
patients’ understanding and responses, and to evaluate the impact of intervention on their behavioural 
changes.  
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